Advertisement

Related Videos

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opening Session Panel Discussion

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Jul
02
Today In Oncology
Lean Body Mass–Based Oxaliplatin Dosing and Risk of Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer
FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple Myeloma
Study Reveals Long-Term Consequences of Chemotherapy on Healthy Blood Cells
Can Hormone Therapy Affect Breast Cancer Risk in Younger Women
Uterine Cancer Incidence and Mortality Rates Projected to Rise Substantially by 2050
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo